Discovery of novel potent peripherally restricted PDE10a inhibitors

被引：0

作者：

Meegalla, Sanath ^{[1
]}

Illig, Carl ^{[1
]}

Huang, Hui ^{[1
]}

Parks, Daniel ^{[1
]}

Chen, Jinsheng ^{[1
]}

Lee, Yu-Kai ^{[1
]}

Wilson, Kenneth ^{[1
]}

Patel, Sharmila ^{[1
]}

Cheung, Wing ^{[1
]}

Lu, Tianbao ^{[1
]}

Kirchner, Thomas ^{[1
]}

Askari, Hossein ^{[1
]}

Patch, Raymond ^{[1
]}

Geisler, John ^{[1
]}

Connelly, Marge ^{[1
]}

Player, Mark ^{[1
]}

机构：

[1] Janssen Res & Dev, Spring House, PA USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

133

引用

页数：2

共 50 条

[41] TARGETING PDE10A IN SCHIZOPHRENIA
Hoefgen, N.
Grunwald, C.
Langen, B.
DRUGS OF THE FUTURE, 2012, 37 (08) : 577 - 589
[42] Discovery of selective biaryl ethers as PDE10A inhibitors: Improvement in potency and mitigation of Pgp-mediated efflux
Rzasa, Robert M.
Hu, Essa
Rumfelt, Shannon
Chen, Ning
Andrews, Kristin L.
Chmait, Samer
Falsey, James R.
Zhong, Wenge
Jones, Adrie D.
Porter, Amy
Louie, Steven W.
Zhao, Xiaoning
Treanor, James J. S.
Allen, Jennifer R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7371 - 7375
[43] Translational pharmacodynamics of phosphodiesterase 10A (PDE10A) inhibitors for treatment of schizophrenia
Nielsen, J.
Steiniger-Brach, B.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 32 - 33
[44] Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia
Yang, Shu-Wei
Smotryski, Jennifer
McElroy, William T.
Tan, Zheng
Ho, Ginny
Tulshian, Deen
Greenlee, William J.
Guzzi, Mario
Zhang, Xiaoping
Mullins, Deborra
Xiao, Li
Hruza, Alan
Chan, Tze-Ming
Rindgen, Diane
Bleickardt, Carina
Hodgson, Robert
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 235 - 239
[45] PDE10A inhibitor in addiction
MU Ying
ZHEN Xue-chu
中国药理学与毒理学杂志, 2017, 31 (05) : 455 - 456
[46] Molecular mechanisms for the putative antipsychotic activity of PDE10A inhibitors: PDE10A regulation of intracellular signaling in striatal medium spiny neurons in culture
Menniti, FS
Brown, T
Collins, M
Fox, C
Kimmel, L
Kleiman, R
Lebel, L
Ryan, A
Schmidt, CJ
Seeger, T
Shrikhande, A
Wong, S
Wylie, R
SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 313 - 314
[47] Advances in the Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 2: Focus on Schizophrenia
Swierczek, Artur
Jankowska, Agnieszka
Chlon-Rzepa, Grazyna
Pawlowski, Maciej
Wyska, Elzbieta
CURRENT DRUG TARGETS, 2019, 20 (16) : 1652 - 1669
[48] Design and optimization of purine derivatives as in vivo active PDE10A inhibitors
Chen, Liu
Chen, Danqi
Tang, Le
Ren, Jing
Chen, Jiaojiao
Zhen, Xuechu
Liu, Yu-Chih
Zhang, Chenhua
Luo, Haibin
Shen, Jingkang
Xiong, Bing
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (13) : 3315 - 3329
[49] Emerging Biology of PDE10A
Wilson, Lindsay S.
Brandon, Nicholas J.
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (03) : 378 - 388
[50] Synthesis of fluorine-containing papaverine analogs as PDE10A inhibitors
Zhang, Zhanbin
Xu, Jinbin
Mach, Robert
Tu, Zhude
JOURNAL OF NUCLEAR MEDICINE, 2009, 50

← 1 2 3 4 5 →